News Room

A collection of press releases, audio content and media clips featuring INFORMS members and their research.

On the left side of the graphic is a caucasian man wearing glasses and a suit. The photo shows him in portrait mode. The right side is blue and has a white logo and text.
News Release

Announcing the results of the 2026 INFORMS Board of Directors election and the new board for 2027.

Read More
A logo on white background
News Release

INFORMS has named 12 distinguished leaders as the 2026 class of INFORMS Fellows, one of the highest honors in the profession.

Read More
A human hand holds a magnifying glass up to a computer screen. The screen is out of focus but the area under the magnifying glass is crystal clear. It appears to be the website for the FDA.
News Release

Most medical devices do not hit the market through rigorous safety testing but by being deemed similar enough to something already approved—the “predicate” device through a mechanism known as the FDA’s 510(k) pathway. But similar is not a synonym for safe. While the assumption may be that substantial equivalence is a reasonable stand-in for a safety review, a share of devices cleared with this method still get recalled, and the FDA spends valuable time reviewing devices the same way, regardless of how risky it is on paper.

Read More

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Media Contact

Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565

INFORMS in the News

What are you looking for?

Type of Content
Topic
The Challenges Vaccine Stocks Face As They Try To Fight Delta Variant

The Challenges Vaccine Stocks Face As They Try To Fight Delta Variant

Investors Business Daily, August 27, 2021

Vaccine stocks Pfizer (PFE) and Moderna (MRNA) think they can get a handle on the coronavirus' delta variant. The two, along with other vaccine makers, have ambitious booster shot plans. But regardless of the outcome, experts say the Covid donnybrook is far from over.

Special edition episode on Covid-19: A conversation with Robert Hanfield

Special edition episode on Covid-19: A conversation with Robert Hanfield

Federal News Network, August 30, 2021

Join host Michael Keegan next week for Special Edition of The Business of Government Hour – COVID-19 and its Impact: a series on how the pandemic has transform government management and operations with guest Dr. Rob Handfield–discussing key steps in building national supply chain immunity.

The Intolerable Wait for a Kids’ Vaccine

The Intolerable Wait for a Kids’ Vaccine

The New York Times, August 30, 2021

Julie Swann, an engineer who studies health systems and models infectious disease at North Carolina State University, leads a team of researchers who recently tried to simulate how the Delta variant of the coronavirus could move through schools in various scenarios. The results, which The Washington Post published over the weekend, were alarming.

Subject Matter Experts in

Supply Chain

View list of experts

Subject Matter Experts in

Healthcare

View list of experts

INFORMS Magazines

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.

Access OR/MS Today Magazine

Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.

Access Analytics Magazine